International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Nov 13, 2024, after the close
10-Q filed Nov 13, 2024, 44 days after period end · 0000950170-24-126268
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $2.18M | $1.97M | $1.70M | $1.84M |
| Net Income | -$125.00K | -$131.00K | -$343.00K | -$165.00K |
| EPS Diluted | -$0.02 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.02 |
| -$0.04 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
